Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends That Matter for Compounding Policies

Posted by Matt Breese on Jan 18, 2018

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is pharmacy compounding regulations.

The U.S. Food and Drug Administration recently issued it's 2018 Compounding Policy Priorities Plan. 

Read More

Topics: Industry Trends

Trends That Matter for Pain Relief

Posted by Matt Breese on Jan 4, 2018

In our weekly Trends that Matter series, we provide infographics, articles and recent news from influencers to highlight general trends affecting the pharmaceutical and healthcare industries. This week's featured topic is pain relief treatments. 

Neighborhood Health Plan (NHP) will soon begin broadly offering certain prevention, rehabilitation and drug-free pain relief treatments and prescriptions cost-free to members.

Read More

Topics: Industry Trends, Payer

Which Disease Areas Are On Your Mind Going Into 2018?

Posted by Matt Breese on Dec 31, 2017

We reviewed activity across major disease areas featured in 2017 MMIT Reality Checks and gathered poll data from pharma brand teams to understand where the biggest buzz is within market access. The following disease areas (in order) is where we received the most interest - some of these surprised us...

Read More

Topics: Specialty, Industry Trends, Market Access, Branding & Marketing

Trends That Matter for Hypertension

Posted by Matt Breese on Dec 28, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from influencers to highlight general trends affecting the pharmaceutical and healthcare industries. This week's featured topic is hypertension. 

A new clinical practice guideline’s lower threshold for hypertension increases the prevalence of the condition to include nearly half of adults in the U.S. But this doesn’t necessarily mean patients below the old standard will require antihypertensive drugs.

Read More

Topics: Industry Trends

Trends That Matter for BCBS Plans

Posted by Matt Breese on Dec 21, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from influencers to highlight general trends affecting the pharmaceutical and healthcare industries. This week's featured topic is Blue Cross and Blue Shield Plans.

With their limited geographic footprint, strong name recognition and broad provider networks, Blue Cross and Blue Shield plans face both challenges and opportunities in market positioning. 

Read More

Topics: Industry Trends

Trends That Matter for Viscosupplements

Posted by Matt Breese on Dec 14, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is viscosupplements,. 

According to our recent payer coverage analysis for viscosupplements, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

Read More

Topics: Specialty, Industry Trends

Trends That Matter for Multiple Sclerosis

Posted by Matt Breese on Dec 7, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is multiple sclerosis treatments. 

According to our recent payer coverage analysis for multiple sclerosis treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

Read More

Topics: Specialty, Industry Trends

Trends That Matter for G-CSF Treatments

Posted by Matt Breese on Nov 30, 2017

 

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is granulocyte-colony stimulating factor (G-CSF) treatments. 

According to MMIT's recent payer coverage analysis for G-CSF treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. Here’s a look at more recent trends.

Read More

Topics: Industry Trends, Market Access, Payer

Trends That Matter for M&A Activity

Posted by Matt Breese on Nov 23, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is merger and acquisition activity.

With rumors swirling that CVS Health Corp. is in talks to purchase Aetna Inc., merger and acquisition activity in the PBM industry is heating up. Here’s a look at recent deals.

Read More

Topics: Industry Trends

Perspectives on Twitter Marketing

Posted by Matt Breese on Nov 14, 2017

If you follow social media trends, you've likely heard the news that Twitter recently increased its messaging limit to 280 characters. The Twitter product team made this change after noticing that 9% of English-language Tweets included exactly 140 characters, indicating that many users were editing the length of their messages.

What does this tech change have to do with pharma? This modification can help pharma marketers make sure their messages are compliant with FDA guidelines, according to Andrew Grojean, Social Media Manager at Intouch Solutions

Read More

Topics: Industry Trends, Branding & Marketing